Exagen Inc (NAS:XGN)
$ 2.75 -0.04 (-1.43%) Market Cap: 47.81 Mil Enterprise Value: 47.91 Mil PE Ratio: 0 PB Ratio: 2.72 GF Score: 70/100

Exagen Inc at William Blair Growth Stock Conference Transcript

Jun 07, 2023 / 07:00PM GMT
Release Date Price: $3.15 (-1.25%)
Dustin Scaringe
William Blair & Company LLC - Analyst

Hi, good afternoon, everyone. My name is Dustin Scaringe, and I work on Andrew Brackmann's team here on diagnostics segment. In this session, we have the team from Exagen joining us. President and CEO John Aballi; CFO, Kamal Adawi; and IR, Ryan Douglas joining us from IR. (Conference Instructions)

Finally, I am required to inform you that for a complete list of research disclosures or potential conflicts of interest, please visit our website at williamblair.com. Okay, with that out of the way, I'll turn it over to John.

John Aballi
Exagen Inc. - President & CEO

Thanks, Dustin. Very good. Awesome. Good afternoon, everyone. Thanks for the opportunity to share a little bit about Exagen and what we're doing in San Diego. We are, from a business model standpoint, a diagnostic laboratory that is delivering solutions, testing solutions, both on the diagnostic, prognostic as well as monitoring standpoint for autoimmune disorders. So look forward to being here and walking you through a little bit

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot